Year: 2015

A friend recently told me she noticed there seemed to be a fad people were jumping on — the running fad. At first I didn't like the sound of it because a fad is something that usually passes. But then I realized, with the obesity rate growing not only in adults but children as well, I see this fad as people's way of finding a way to fight…

Go to Source

(Reuters) – Argos Therapeutics Inc said its experimental drug to treat HIV failed to meet its main goal in a mid-stage study, sending the company’s shares down 27 percent in premarket trade. The main goal of the trial required the drug to lower the median viral load more than a placebo in HIV-infected patients after 12 weeks of interruption of antiretroviral therapy. (Reporting by Rosmi Shaji in Bengaluru; Editing by Savio D’Souza)
Go to Source

(Reuters) – An experimental drug from Biogen Idec Inc showed evidence of biological repair of the optic nerve in a mid-stage study in patients with acute optic neuritis, an inflammation of the optic nerve that can lead to vision loss. The drug is also being tested in patients with multiple sclerosis, an inflammatory disease that attacks the protective covers of nerve cells. Current treatments focus on decreasing inflammation rather than regenerating cells. That study's results are due in 2016, the company said. …

Go to Source